BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10235368)

  • 1. Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study.
    Chen Q; Luo G; Li B; Samaranayake LP
    J Oral Pathol Med; 1999 Apr; 28(4):158-64. PubMed ID: 10235368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of CDK4 protein in oral carcinogenesis].
    Chen Q; Luo G; Li B; He Z; Chen L; Cao X; Nie M
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Feb; 17(1):8-10. PubMed ID: 12539309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bax protein expression in the carcinogenesis of human oral mucosa].
    Zeng X; Chen Q; Li B; Tan N
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma.
    Yakushiji T; Noma H; Shibahara T; Arai K; Yamamoto N; Tanaka C; Uzawa K; Tanzawa H
    Bull Tokyo Dent Coll; 2001 Aug; 42(3):159-68. PubMed ID: 11806150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.
    Turatti E; da Costa Neves A; de Magalhães MH; de Sousa SO
    J Oral Sci; 2005 Jun; 47(2):71-6. PubMed ID: 16050486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas.
    Saito T; Nakajima T; Mogi K
    J Oral Pathol Med; 1999 May; 28(5):226-32. PubMed ID: 10226946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pRb and p16 protein alterations in human oral tumorigenesis.
    Pande P; Mathur M; Shukla NK; Ralhan R
    Oral Oncol; 1998 Sep; 34(5):396-403. PubMed ID: 9861348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
    Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
    J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse expression of Cdk4 and p16 in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Goto M; Inohara T; Sugimoto K; Tai Y; Hando T; Tokuda M
    Gynecol Oncol; 2000 Nov; 79(2):230-7. PubMed ID: 11063650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p16 and cyclin-dependent kinase 4 proteins in primary breast carcinomas.
    Ito Y; Kobayashi T; Takeda T; Nakano Y; Tamaki Y; Komoike Y; Wakasugi E; Shin E; Takatsuka Y; Kikkawa N; Matsuura N; Monden M
    Oncology; 1997; 54(6):508-15. PubMed ID: 9394849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
    Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
    Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
    Suzuki H; Sugimura H; Hashimoto K
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.
    Halvorsen OJ; Høstmark J; Haukaas S; Høisaeter PA; Akslen LA
    Cancer; 2000 Jan; 88(2):416-24. PubMed ID: 10640976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R; Das BR
    Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
    Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical characterization of cyclin dependent kinase-4 in different histological grades of oral leukoplakia and oral squamous cell carcinoma.
    Shyam N; Rao NN; Narang RD; George J; Bommu SR; Kiran G
    J Oral Maxillofac Pathol; 2014 Jan; 18(1):36-41. PubMed ID: 24959035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
    Bachmann IM; Straume O; Akslen LA
    Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type endometrial carcinoma.
    Shiozawa T; Nikaido T; Shimizu M; Zhai Y; Fujii S
    Cancer; 1997 Dec; 80(12):2250-6. PubMed ID: 9404701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.